×
About 3,368 results

ALLMedicine™ Endophthalmitis Center

Research & Reviews  1,170 results

Clinical presentations, microbiology and factors affecting management outcomes in lens ...
https://doi.org/10.1097/IAE.0000000000003419
Retina (Philadelphia, Pa.); Dave VP, Ramamurthy S et. al.

Jan 25th, 2022 - To describe the clinical presentations, microbiology and factors affecting management outcomes in lens abscess with concurrent endophthalmitis. A retrospective, consecutive, non-comparative series including cases of endophthalmitis with concurrent...

The Pandemic Not Associated with Endophthalmitis Decrease after Anti-VEGF Injections.
https://doi.org/10.1016/j.ophtha.2022.01.009
Ophthalmology Lum F, Li S et. al.

Jan 19th, 2022 - Based on an analysis of 4,206,234 anti-VEGF intravitreal injections in the IRIS Registry database, there was no observed difference in rates of presumed endophthalmitis after intravitreal injections pre-pandemic vs. during the pandemic in 2020.

Leukocoria in a child due to endophthalmitis caused by an intraocular eyelash.
https://doi.org/10.1016/j.ajo.2022.01.008
American Journal of Ophthalmology; Fukuda K, Miura Y et. al.

Jan 17th, 2022 - Leukocoria in a child due to endophthalmitis caused by an intraocular eyelash.|2022|Fukuda K,Miura Y,Iguchi M,|

Changing operating room practices: the effect on postoperative endophthalmitis rates fo...
https://doi.org/10.1136/bjophthalmol-2021-320506
The British Journal of Ophthalmology; Haripriya A, Ravindran RD et. al.

Jan 13th, 2022 - To determine whether four new operating room (OR) protocols instituted because of COVID-19 reduced the cataract surgical postoperative endophthalmitis rate (POE). Retrospective, sequential, clinical registry study. 85 552 sequential patients under...

Metagenomic Next-generation Sequencing Detects Pathogens in Endophthalmitis Patients.
https://doi.org/10.1097/IAE.0000000000003406
Retina (Philadelphia, Pa.); Zhu J, Xia H et. al.

Jan 13th, 2022 - To investigate the utility of metagenomic next-generation sequencing (mNGS) in identifying the pathogens in endophthalmitis. In this prospective study, 36 cases of endophthalmitis were recruited. All patients received surgical treatment and intrao...

see more →

Guidelines  1 results

Intravitreal injection technique and monitoring: updated guidelines of an expert panel.
https://doi.org/10.1097/IAE.0000000000000399
Retina (Philadelphia, Pa.); Avery RL, Bakri SJ et. al.

Dec 10th, 2014 - To review evidence and provide updated guidelines on intravitreal (IVT) injection technique and monitoring. A review of the published literature on IVT injection from 2004 to 2014 formed the basis for round table deliberations by an expert panel o...

see more →

Clinicaltrials.gov  37 results

Safety and Efficacy of Topical Moxifloxacin for Prevention of Post-Traumatic Endophthalmitis: Randomized Controlled Clinical Trial
https://clinicaltrials.gov/ct2/show/NCT05162625

Dec 17th, 2021 - Patients diagnosed with OGI that requires surgery will be evaluated regarding visual acuity, biomicroscopy and fundoscopy, considering that the latter may not be possible in some cases due to the trauma severity. Those who, after being informed ab...

Evaluation do Early Pars Plana Vitrectomy in Acute Endophthalmitis
https://clinicaltrials.gov/ct2/show/NCT04192994

Dec 7th, 2021 - Endophthalmitis, a severe inflammatory ocular condition with profound visual impairment that can lead to irreversible visual loss, requires immediate treatment. The only multicenter randomized trial of different forms of acute endophthalmitis trea...

Long-shaft Vitrectomy Probe in Highly Myopic Eyes
https://clinicaltrials.gov/ct2/show/NCT04902170

Nov 19th, 2021 - This study aimed to compare the safety and efficacy of vitrectomy probe with different shaft lengths in vitreoretinal surgery of highly myopic patients. In this randomized controlled study, highly myopic patients who had axial length more than 26 ...

Use Of Intracameral Moxifloxacin For Prophylaxis Of Open Globe Endophthalmitis
https://clinicaltrials.gov/ct2/show/NCT05079854

Nov 10th, 2021 - Endophthalmitis is a severe inflammatory eye condition with profound impairment of vision, which can lead to irreversible visual loss and requires immediate treatment. There is no way to completely prevent endophthalmitis, however, through prophyl...

A Feasibility Randomised Controlled Trial of Early Vitrectomy for Post-operative Exogenous Endophthalmitis
https://clinicaltrials.gov/ct2/show/NCT04522661

Aug 25th, 2021 - The EVIAN Study is a multicentre, feasibility, randomised controlled trial to evaluate the effect of early vitrectomy surgery on acute endophthalmitis. Patients with postoperative exogenous endophthalmitis following any ocular surgery/procedure/in...

see more →

News  139 results

Surgical Removal of a Retained Lens Fragment After Cataract Surgery May Improve Patient Outcomes
https://www.medscape.com/viewarticle/961715

Oct 27th, 2021 - Just the other week, one of our residents presented a case on a retained lens fragment (RLF) that he had to manage at the local VA hospital. He presented his case and approach during our monthly M&M conference. He noted that his patient had a stra...

First Implant Approved for Wet Macular Degeneration
https://www.medscape.com/viewarticle/961623

Oct 26th, 2021 - The US Food and Drug Administration for the first time approved an implant to treat neovascular age-related macular degeneration (nAMD). By releasing a constant dose of ranibizumab, the implanted port delivery system (Susvimo) made by Genentech/Ro...

FDA Approves Drugs for Wet AMD, Macular Edema Due to Uveitis
https://www.medscape.com/viewarticle/961565

Oct 25th, 2021 - Ophthalmologists in the US will soon have more options in their toolkit to manage neovascular age-related macular degeneration (AMD) and macular edema associated with uveitis. Susvimo, a 100 mg/mL ranibizumab injection for intravitreal use via ocu...

Continuous-Release Anti-VEGF Device for AMD Wins FDA Approval
https://www.medpagetoday.com/ophthalmology/generalophthalmology/95225

Oct 23rd, 2021 - The FDA has approved a first-of-its kind continuous delivery system for anti-VEGF therapy for neovascular (wet) age-related macular degeneration (AMD). The Susvimo ocular implant continuously releases 100 mg/mL of ranibizumab directly to the retin...

Face Masks May Reduce Endophthalmitis 
https://www.medscape.com/viewarticle/960650

Oct 11th, 2021 - SAN ANTONIO — When everyone in the room wears face masks, patients may be less likely to get endophthalmitis during intravitreal injections, researchers say. "We can't eliminate the risk, but we can reduce it," said Sunir Garg, MD, a professor of ...

see more →